SANDOZ RIVASTIGMINE
SANDOZ CANADA INCORPORATED
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is SANDOZ RIVASTIGMINE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that SANDOZ RIVASTIGMINE 3MG has been permanently discontinued (last updated December 11, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is SANDOZ RIVASTIGMINE not available?
The reason the manufacturer reported: Manufacturing issues.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
NOVO-RIVASTIGMINE
NOVOPHARM LIMITED
Other Products
EXELON
KNIGHT THERAPEUTICS INC.
PMS-RIVASTIGMINE
PHARMASCIENCE INC
APO-RIVASTIGMINE
APOTEX INC
RIVASTIGMINE TARTRATE CAPSULES
DR REDDY'S LABORATORIES LTD
MED-RIVASTIGMINE
GENERIC MEDICAL PARTNERS INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02324571
Strength
3MG
Dosage Form
CAPSULE
Route
ORAL
Compare with another product →
Shortage History
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495910
DIN 02495937
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759